Nyxoah SA
Develops hypoglossal neurostimulation therapy for Obstructive Sleep Apnea (OSA).
NYXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974358906
- LEI:
- 5493002O1ESKZ18OXR80
- Country:
- Belgium
- Address:
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
- Website:
- https://www.nyxoah.com/
- Sector:
- Manufacturing
Description
Nyxoah SA is a medical technology company focused on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, a hypoglossal neurostimulation (HNS) therapy designed for patients with moderate to severe OSA. The system features a patient-centered, leadless, and battery-free implantable stimulator. It functions by providing bilateral stimulation to the hypoglossal nerve, which controls tongue muscles, to maintain an open airway during sleep.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-05-12 07:00 |
DOC 9 - Nyxoah - Statutory accounts 2022 - FR.PDF
|
French | 1.0 MB | ||
| 2023-05-12 07:00 |
DOC 12 - Nyxoah - Auditor report statutory accounts 2022 - ENG.pdf
|
English | 309.9 KB | ||
| 2023-05-12 07:00 |
DOC 3 - Nyxoah - ASM 2023 - Attendance notification form - ENG FR.pdf
|
French | 195.5 KB | ||
| 2023-05-12 07:00 |
DOC 1 - Nyxoah - ASM 2023 - Convening notice - ENG.pdf
|
English | 251.6 KB | ||
| 2023-05-12 07:00 |
DOC 2 - Nyxoah - ASM 2023 - Convening notice - FR.pdf
|
French | 255.3 KB | ||
| 2023-04-20 22:30 |
ResMed 2023 03 30 - transparency notification (signed).pdf
|
English | 271.2 KB | ||
| 2023-04-20 22:30 |
Togehter 2023 03 30 - transparency notification (signed).pdf
|
Dutch | 813.5 KB | ||
| 2023-04-20 22:30 |
2023 04 20 PR Transparency notifications 2023 04 (Together Resmed) (ENG).pdf
|
English | 166.9 KB | ||
| 2023-04-20 22:30 |
2023 04 20 PR Transparency notifications 2023 04 (Together Resmed) (FR).pdf
|
French | 168.3 KB | ||
| 2023-04-17 22:30 |
2023 04 17 22u30 press-release-number-of-shares-eng.pdf
|
English | 165.0 KB | ||
| 2023-04-17 22:30 |
2023 04 17 22u30 press-release-number-of-shares-fr.pdf
|
French | 163.6 KB | ||
| 2023-04-13 22:05 |
2023 04 13 22u05 english-atm-final.pdf
|
English | 257.8 KB | ||
| 2023-04-13 22:05 |
2023 04 13 22u05 french-atm-final.pdf
|
French | 153.8 KB | ||
| 2023-03-31 22:30 |
2023 03 31 22u30 english-number-of-shares-final.pdf
|
English | 163.9 KB | ||
| 2023-03-31 22:30 |
2023 03 31 22u30 french-number-of-shares-final.pdf
|
French | 162.3 KB |
Automate Your Workflow. Get a real-time feed of all Nyxoah SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nyxoah SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nyxoah SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-19 | Laurette Renard | Close relation | Sell | 5,000 | 39,000.00 EUR |
| 2024-09-05 | Hambrecht Jürgen | Board | Sell | 980,000 | 6,840,400.00 EUR |
| 2024-09-05 | JH Capital GmbH | Close relation | Buy | 980,000 | 6,840,400.00 EUR |
| 2024-01-25 | Tompkins Patrick | Executive member | Buy | 2,000 | 18,020.00 USD |
| 2023-12-28 | Onkelinx Bruno | Executive member | Buy | 470 | 2,035.10 EUR |
| 2023-08-18 | Moreau Loïc | Executive member | Buy | 6,427 | 48,416.52 EUR |
| 2023-08-14 | Moreau Loïc | Executive member | Buy | 3,800 | 28,697.60 EUR |
| 2023-08-11 | Moreau Loïc | Executive member | Buy | 3,000 | 21,957.60 EUR |
| 2023-07-04 | Wildman Ventures LLC | Board | Buy | 25,000 | N/A |
| 2023-07-02 | Gianello Pierre | Board | Buy | 25,000 | N/A |
Peer Companies
